Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
about
Biologics and Pediatric Generalized Pustular Psoriasis: An Emerging Therapeutic TrendPharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsPromising biological therapies for ulcerative colitis: A review of the literatureRare gastrointestinal lymphomas: The endoscopic investigationThe human disease network in terms of dysfunctional regulatory mechanismsAssessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug ScreeningInfliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?Gamma-delta t-cell lymphomas.Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceManagement of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly.Infliximab treatment for refractory kawasaki disease in korean children.European evidence-based Consensus on the management of ulcerative colitis: Current management.Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot studyMedical management of Crohn's disease.Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.Ulcerative colitis: current treatment strategies and future prospects.Management of psoriasis in adolescence.Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trialImpact of enteral nutrition on energy metabolism in patients with Crohn's disease.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.Infliximab therapy in pediatric Crohn's disease: a review.Unusual case of B cell lymphoma after immunosuppressive treatment for psoriasisCancer and immunomodulators in inflammatory bowel diseases.Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease.Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience.DNetDB: The human disease network database based on dysfunctional regulation mechanismTherapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.Change in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprineHepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated DiseaseMode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases.Recent advances in the medical therapy of Crohn's disease in childhood.Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study.Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.Infliximab therapy for pediatric Crohn's disease.Pathobiology of T-cell and NK-cell lymphomas.
P2860
Q26741357-34E022DF-0A49-4815-BFBE-5E017BA40CF0Q26768280-C863F5F4-F11A-48DE-BB61-FA1A26AE01FBQ26776139-2B2BD6C4-6ED6-4C08-BA42-3D37B27126E7Q26799041-0B5146E6-4DE8-48A0-9DED-6E8A5EF91902Q28550156-C4204237-1951-4ACB-9113-F8AF1B95D47DQ28552630-6D4DFABB-55D2-4896-8601-28CBAD19DB70Q28741471-7D09B2CA-E1C0-4304-9C2B-F99B89F971C9Q33417290-FCBCA8D5-B548-4516-99FB-4C066AAD9621Q33750759-197EAEB1-95C8-45D5-80FB-D30CD01068C2Q33819473-78D5CF7D-AAC6-4444-864F-25B12B96C325Q33883235-DD15D4D9-0080-4C27-9291-8CC73B8D9712Q33916303-69CF4E0B-ED0A-4920-AD2C-F088F79867BCQ33955993-4DF6E788-73E8-47D5-942B-7EE452DCCF23Q34021198-9A0501DF-6D89-44CE-997B-0CE1FDDE8A65Q34025054-563F2582-8901-441E-BF75-9E5A46AB438BQ34034566-BF1ADEFE-0A09-4F60-817B-67688FC34368Q34046139-F0A88A18-E722-494F-9468-0806AB63B777Q34077378-C047D48C-CAAA-48B6-AA65-3174C0BB9542Q34078707-90513EA7-EBF1-4801-A9B7-9AF1631C3A20Q34358060-A0EFAD51-F791-4AB7-84C4-C0244BEAE7FBQ34408967-F451E23A-CCB6-47F6-AE9D-97907B078EBBQ34415058-D92F7E79-FCAB-4A6B-9F60-2DB1338BAFB6Q34767921-2E7BABB5-B89A-491D-A06B-BAF7B07850EBQ35012146-C236876B-E303-4B6D-B4A8-DAFE27FBF221Q35026302-A3CA4806-CA6C-4207-ACED-0C9A51171402Q35026358-D47CD27F-0745-41E9-9516-A6499779D352Q35501279-CC970652-A784-4D9F-A568-65B8CD2B2B8BQ35534959-13337CF8-3B88-4582-8974-59127C8BB6DCQ35561386-71B410BB-F46B-462A-A4C2-510037A2C6C7Q35777889-34FF0056-578E-4E8D-9812-4553E2B7B9A5Q36025424-706456EB-B699-48E8-83BA-672EEBC3ACFCQ36054928-E960CB86-7A8E-4F95-8500-21A9C257AFFFQ36650158-F1DB8BA4-35B8-4C46-B21A-39B04DDC6E3CQ36812503-2B8C2C8C-A59C-4B00-B7D9-9554ECE9C472Q36897403-602BE78C-BC30-4A1D-9FE6-5AD8BC3C22F2Q36968175-E1C1030D-CB76-4EE2-89C0-2E77E15A6187Q36983642-6FC16A4B-58C7-4632-9D40-98A7FC691D23Q37009469-515810C7-33AE-482A-AC6F-8BCBA0F64783Q37012073-F059CD7C-A2F8-41B5-B944-0E7CEA609450Q37033993-C52FF4AB-ABA2-42CF-908C-3BCB52E4672F
P2860
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@ast
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@en
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@nl
type
label
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@ast
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@en
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@nl
prefLabel
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@ast
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@en
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@nl
P2093
P921
P3181
P1476
Hepatosplenic T cell lymphoma ...... for inflammatory bowel disease
@en
P2093
Ann Corken Mackey
Lanh Green
Li-Ching Liang
Mark Avigan
Patricia Dinndorf
P3181
P356
10.1097/MPG.0B013E31802F6424
P407
P577
2007-02-01T00:00:00Z